Gout – Talk Bio

Actionable Insights Powered by AI

Takeda to Discontinue Uloric: A Gradual Decline of the Gout Medication

3 months ago talkbio0Tagged Cardiovascular system, Discontinuation (procedure), Gout, Risk, scrutiny, Takeda, Uloric, United States Food and Drug Administration

Takeda, Uloric, gout medication, discontinuation, cardiovascular risks, FDA scrutiny

George Church’s GRObio Secures $60 Million to Advance Gout Treatment into Clinical Trials

9 months ago talkbio0Tagged biotech, Clinical Trials, George Church, Gout, GRObio

GRObio, George Church, Gout Treatment, Clinical Trials, Biotech Funding